Due to Pandemic, Japan Extends Permission to Conduct GCP Compliance Inspections Remotely
Seeking to ensure clinical trials are accurate, credible, and safe while protecting the health of its personnel during the COVID-19 pandemic, Japanese regulators will continue to conduct Good Clinical Practice (GCP) inspections remotely through April 1, 2021. The announcement by Japan’s Pharmaceutical... Read More